Escin suppresses HMGB1-induced overexpression of aquaporin-1 and increased permeability in endothelial cells

FEBS Open Bio. 2019 May;9(5):891-900. doi: 10.1002/2211-5463.12622. Epub 2019 Apr 10.

Abstract

Escin, a natural triterpene saponin mixture obtained from the horse chestnut tree (Aesculus hippocastanum), has been used for the treatment of chronic venous insufficiency (CVI), hemorrhoids, and edema. However, it is unclear how escin protects against endothelial barrier dysfunction induced by pro-inflammatory high mobility group protein 1 (HMGB1). Here, we report that escin can suppress (a) HMGB1-induced overexpression of the aquaporin-1 (AQP1) water channel in endothelial cells and (b) HMGB1-induced increases in endothelial cell permeability. This is the first report that escin inhibits AQP1 and alleviates barrier dysfunction in HMGB1-induced inflammatory response.

Keywords: aquaporin-1; barrier dysfunction; endothelial cells; escin; high mobility group protein 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aquaporin 1 / genetics*
  • Aquaporin 1 / metabolism
  • Cardiovascular Agents / pharmacology*
  • Escin / pharmacology*
  • Gene Expression Regulation / drug effects*
  • HMGB1 Protein / genetics*
  • HMGB1 Protein / metabolism
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / physiology
  • Humans
  • Permeability

Substances

  • AQP1 protein, human
  • Cardiovascular Agents
  • HMGB1 Protein
  • HMGB1 protein, human
  • Aquaporin 1
  • Escin